Washington Trust Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48K | Hold |
264
| – | – | ﹤0.01% | 599 |
|
|
2025
Q1 | $1.43K | Hold |
264
| – | – | ﹤0.01% | 617 |
|
|
2024
Q4 | $1.97K | Hold |
264
| – | – | ﹤0.01% | 619 |
|
|
2024
Q3 | $2.11K | Hold |
264
| – | – | ﹤0.01% | 634 |
|
|
2024
Q2 | $2.3K | Hold |
264
| – | – | ﹤0.01% | 625 |
|
|
2024
Q1 | $5.46K | Sell |
264
-68
| -20% | -$1.41K | ﹤0.01% | 561 |
|
|
2023
Q4 | $7.67K | Hold |
332
| – | – | ﹤0.01% | 518 |
|
|
2023
Q3 | $2.65K | Hold |
332
| – | – | ﹤0.01% | 623 |
|
|
2023
Q2 | $2.89K | Hold |
332
| – | – | ﹤0.01% | 607 |
|
|
2023
Q1 | $977 | Hold |
332
| – | – | ﹤0.01% | 759 |
|
|
2022
Q4 | $1.16K | Hold |
332
| – | – | ﹤0.01% | 760 |
|
|
2022
Q3 | $3K | Buy |
332
+106
| +47% | +$958 | ﹤0.01% | 792 |
|
|
2022
Q2 | $2K | Hold |
226
| – | – | ﹤0.01% | 874 |
|
|
2022
Q1 | $3K | Hold |
226
| – | – | ﹤0.01% | 892 |
|
|
2021
Q4 | $3K | Buy |
+226
| New | +$3K | ﹤0.01% | 915 |
|